Metabolic tumor burden as a prognostic indicator after neoadjuvant chemotherapy in pancreatic cancer.
Lee W, Oh M, Kim JS, Sung M, Hong K, Kwak BJ, Park Y, Jun E, Song KB, Hwang DW, Lee JH, Yoo C, Kim KP, Park I, Jeong JH, Chang HM, Ryoo BY, Lee JB, Kim SC.
Lee W, et al. Among authors: park y, park i.
Int J Surg. 2024 Jul 1;110(7):4074-4082. doi: 10.1097/JS9.0000000000001389.
Int J Surg. 2024.
PMID: 38537071
Free PMC article.